Petco Health and Wellness Company, Inc. (WOOF)
Official siteCONSUMER CYCLICAL • SPECIALTY RETAIL • NASDAQ
Market Cap: $814.86M
Last updated: Nov 17, 2026 at 11:06 AM ET
Petco Health and Wellness Company, Inc. (WOOF) Financials: Revenue, Profit and Cash Flow
Petco Health and Wellness Company reported revenue of $5.96B for the fiscal year ended Jan 31, 2026, down 2.5% from the year before. That year, net income was $9.07M with a net margin of 0.2%, operating cash flow was $314.05M and free cash flow was $186.95M. The quarter ended Jul 31, 2026 had revenue of $1.49B and net income of $38.66M.
Revenue and Margins
The operating margin was 2.0% in the fiscal year ended Jan 2026. Over the 10 years to Jan 2026, revenue grew from $2.13B, a compound annual rate of 10.8%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Jan 2026 | $5.96B | -2.5% | 38.7% | 2.0% | 0.2% |
| Jan 2025 | $6.12B | -2.2% | 38.0% | 0.1% | -1.7% |
| Jan 2024 | $6.26B | +3.6% | 37.6% | -18.9% | -20.5% |
| Jan 2023 | $6.04B | +3.9% | 40.2% | 3.7% | 1.5% |
| Jan 2022 | $5.81B | +18.0% | 41.8% | 4.6% | 2.8% |
| Jan 2021 | $4.92B | +11.0% | 42.8% | 4.0% | -0.6% |
| Jan 2020 | $4.43B | +1.0% | 43.0% | 2.5% | -2.3% |
| Jan 2019 | $4.39B | N/A | 43.4% | -4.9% | -9.4% |
| Jan 2017 | $2.52B | +18.0% | 23.5% | 15.0% | 8.6% |
| Jan 2016 | $2.13B | N/A | 23.9% | 17.2% | 10.1% |
Income Statement
In the fiscal year ended Jan 2026, net income turned positive after a loss the year before. In the quarter ended Jul 2026, net income rose 176.7% from the same quarter a year earlier.
Annual
| Line item | Jan 2026 | Jan 2025 | Jan 2024 | Jan 2023 | Jan 2022 | Jan 2021 | Jan 2020 | Jan 2019 | Jan 2017 | Jan 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5.96B | $6.12B | $6.26B | $6.04B | $5.81B | $4.92B | $4.43B | $4.39B | $2.52B | $2.13B |
| Cost of revenue | $3.66B | $3.79B | $3.90B | $3.61B | $3.38B | $2.81B | $2.53B | $2.49B | $1.92B | $1.62B |
| Gross profit | $2.31B | $2.32B | $2.35B | $2.43B | $2.43B | $2.11B | $1.91B | $1.90B | $592.06M | $510.07M |
| Operating income | $120.43M | $7.05M | -$1.18B | $225.56M | $266.07M | $194.42M | $110.60M | -$214.72M | $377.88M | $367.80M |
| Net income | $9.07M | -$101.82M | -$1.28B | $89.91M | $159.81M | -$31.74M | -$103.98M | -$413.79M | $217.40M | $216.10M |
| EBITDA | $322.17M | $225.26M | -$967.00M | $411.66M | $478.80M | $393.50M | $307.60M | -$14.66M | $482.47M | $451.23M |
Quarterly
| Line item | Jul 2026 | Apr 2026 | Jan 2026 | Oct 2025 | Jul 2025 | Apr 2025 | Jan 2025 | Oct 2024 | Jul 2024 | Apr 2024 | Jan 2024 | Oct 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.49B | $1.50B | $1.52B | $1.46B | $1.49B | $1.49B | $1.55B | $1.51B | $1.52B | $1.53B | $1.67B | $1.49B |
| Gross profit | $591.15M | $574.42M | $580.77M | $569.01M | $585.32M | $569.97M | $589.26M | $575.76M | $580.73M | $578.66M | $606.35M | $550.00M |
| Operating income | $47.81M | $24.63M | $31.86M | $29.20M | $43.02M | $16.36M | $17.39M | $3.98M | $2.47M | -$16.78M | $166.00K | -$1.23B |
| Net income | $38.66M | -$15.15M | -$2.58M | $9.33M | $13.97M | -$11.66M | -$13.84M | -$16.67M | -$24.82M | -$46.48M | -$22.57M | -$1.24B |
Balance Sheet
As of Jan 2026, total debt of $1.49B exceeded cash and equivalents by $1.24B.
Annual
| Line item | Jan 2026 | Jan 2025 | Jan 2024 | Jan 2023 | Jan 2022 | Jan 2021 | Jan 2020 | Jan 2019 | Jan 2017 | Jan 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $5.17B | $5.19B | $5.36B | $6.61B | $5.47B | $6.08B | $6.16B | $4.92B | $3.37B | $2.51B |
| Current assets | $1.02B | $973.62M | $951.74M | $1.02B | $1.07B | $777.55M | $711.00M | $761.61M | $281.05M | $282.16M |
| Cash and equivalents | $256.74M | $165.76M | $125.43M | $201.90M | $211.60M | $111.40M | $148.78M | $180.65M | $81.41M | $98.89M |
| Total liabilities | $4.01B | $4.08B | $4.18B | $4.23B | $4.24B | $4.02B | $5.59B | $4.29B | $1.90B | $1.26B |
| Short-term debt | $4.61M | $5.35M | $15.96M | $22.79M | $287.66M | $2.20M | $306.87M | $28.35M | $38.32M | $33.62M |
| Long-term debt | $1.49B | $1.58B | $1.58B | $1.63B | $1.64B | $1.65B | $3.23B | $3.20B | N/A | N/A |
| Shareholder equity | $1.16B | $1.11B | $1.18B | $2.38B | $2.27B | $2.07B | $569.39M | $637.91M | $1.47B | $1.24B |
Quarterly
| Line item | Jul 2026 | Apr 2026 | Jan 2026 | Oct 2025 | Jul 2025 | Apr 2025 | Jan 2025 | Oct 2024 | Jul 2024 | Apr 2024 | Jan 2024 | Oct 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $5.17B | $5.08B | $5.17B | $5.21B | $5.15B | $5.12B | $5.19B | $5.21B | $5.28B | $5.26B | $5.36B | $5.43B |
| Total liabilities | $3.96B | $3.93B | $4.01B | $4.05B | $4.01B | $4.01B | $4.08B | $4.09B | $4.15B | $4.10B | $4.18B | $4.23B |
| Cash and equivalents | $293.50M | $166.80M | $256.74M | $237.41M | $188.75M | $133.34M | $165.76M | $116.67M | $127.62M | $89.72M | $125.43M | $139.78M |
| Shareholder equity | $1.21B | $1.16B | $1.16B | $1.16B | $1.14B | $1.11B | $1.11B | $1.12B | $1.13B | $1.16B | $1.18B | $1.19B |
Cash Flow
In the fiscal year ended Jan 2026, free cash flow was 59.5% of operating cash flow.
Annual
| Line item | Jan 2026 | Jan 2025 | Jan 2024 | Jan 2023 | Jan 2022 | Jan 2021 | Jan 2020 | Jan 2019 | Jan 2017 | Jan 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $314.05M | $177.67M | $215.72M | $346.00M | $358.21M | $268.62M | $110.34M | $203.20M | $389.83M | $317.55M |
| Capital expenditures | $127.10M | $127.99M | $225.60M | $278.02M | $239.11M | $159.56M | $156.91M | $148.36M | $122.95M | $95.23M |
| Free cash flow | $186.95M | $49.68M | -$9.88M | $67.98M | $119.11M | $109.06M | -$46.57M | $54.84M | $266.88M | $222.31M |
| Dividends paid | N/A | N/A | N/A | $11.76M | $308.00K | $476.00M | N/A | N/A | N/A | N/A |
| Share repurchases | N/A | N/A | N/A | N/A | $3.84M | $105.00K | $0 | N/A | N/A | N/A |
| Investing cash flow | -$124.56M | -$123.90M | -$207.44M | -$320.32M | -$237.08M | -$157.19M | -$139.04M | -$142.68M | N/A | N/A |
| Financing cash flow | -$101.75M | -$8.75M | -$85.35M | -$33.84M | -$18.78M | -$146.61M | -$3.07M | -$32.10M | $421.32M | -$95.27M |
Quarterly
| Line item | Jul 2026 | Apr 2026 | Jan 2026 | Oct 2025 | Jul 2025 | Apr 2025 | Jan 2025 | Oct 2024 | Jul 2024 | Apr 2024 | Jan 2024 | Oct 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $161.55M | -$30.97M | $153.52M | $90.09M | $85.89M | -$15.45M | $95.99M | $20.72M | $69.37M | -$8.41M | $47.02M | $34.43M |
| Capital expenditures | $31.64M | $38.15M | $37.14M | $29.44M | $32.10M | $28.41M | $36.95M | $31.01M | $27.39M | $32.64M | $49.07M | $62.51M |
| Free cash flow | $129.92M | -$69.12M | $116.39M | $60.65M | $53.79M | -$43.87M | $59.04M | -$10.29M | $41.98M | -$41.05M | -$2.04M | -$28.08M |
Frequently Asked Questions About WOOF
What is Petco Health and Wellness Company's annual revenue?
Petco Health and Wellness Company reported revenue of $5.96B for the fiscal year ended Jan 31, 2026.
How fast is Petco Health and Wellness Company's revenue growing?
Revenue was down 2.5% for the fiscal year ended Jan 31, 2026 compared with the year before. The compound annual revenue growth rate over 3 years was -0.4%.
Is Petco Health and Wellness Company profitable?
Yes. Petco Health and Wellness Company reported net income of $9.07M for the fiscal year ended Jan 31, 2026, with a net margin of 0.2%.
How much free cash flow does WOOF generate?
For the fiscal year ended Jan 31, 2026, operating cash flow of $314.05M minus capital expenditures of $127.10M produced free cash flow of $186.95M.
How much debt does Petco Health and Wellness Company have?
The balance sheet dated Jan 31, 2026 reported long-term debt of $1.49B, short-term debt of $4.61M and cash and equivalents of $256.74M.
WOOF pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors